20-31824298-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_033118.4(MYLK2):​c.918C>T​(p.Ala306Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,613,686 control chromosomes in the GnomAD database, including 319 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 21 hom., cov: 33)
Exomes 𝑓: 0.017 ( 298 hom. )

Consequence

MYLK2
NM_033118.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.839

Publications

7 publications found
Variant links:
Genes affected
MYLK2 (HGNC:16243): (myosin light chain kinase 2) This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]
MYLK2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 20-31824298-C-T is Benign according to our data. Variant chr20-31824298-C-T is described in ClinVar as Benign. ClinVar VariationId is 36654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.839 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0116 (1770/152280) while in subpopulation NFE AF = 0.0186 (1267/68020). AF 95% confidence interval is 0.0178. There are 21 homozygotes in GnomAd4. There are 831 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1770 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYLK2NM_033118.4 linkc.918C>T p.Ala306Ala synonymous_variant Exon 6 of 13 ENST00000375985.5 NP_149109.1 Q9H1R3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYLK2ENST00000375985.5 linkc.918C>T p.Ala306Ala synonymous_variant Exon 6 of 13 1 NM_033118.4 ENSP00000365152.4 Q9H1R3
MYLK2ENST00000375994.6 linkc.918C>T p.Ala306Ala synonymous_variant Exon 5 of 12 1 ENSP00000365162.2 Q9H1R3

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1771
AN:
152162
Hom.:
21
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00362
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0150
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00745
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0186
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.0107
AC:
2665
AN:
249978
AF XY:
0.0111
show subpopulations
Gnomad AFR exome
AF:
0.00366
Gnomad AMR exome
AF:
0.00750
Gnomad ASJ exome
AF:
0.00239
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00242
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0151
GnomAD4 exome
AF:
0.0174
AC:
25356
AN:
1461406
Hom.:
298
Cov.:
33
AF XY:
0.0170
AC XY:
12370
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.00370
AC:
124
AN:
33476
American (AMR)
AF:
0.00837
AC:
374
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26124
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.00830
AC:
715
AN:
86130
European-Finnish (FIN)
AF:
0.00384
AC:
205
AN:
53346
Middle Eastern (MID)
AF:
0.00780
AC:
45
AN:
5766
European-Non Finnish (NFE)
AF:
0.0207
AC:
22988
AN:
1111810
Other (OTH)
AF:
0.0142
AC:
859
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1527
3055
4582
6110
7637
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0116
AC:
1770
AN:
152280
Hom.:
21
Cov.:
33
AF XY:
0.0112
AC XY:
831
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00361
AC:
150
AN:
41564
American (AMR)
AF:
0.0150
AC:
229
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.00725
AC:
35
AN:
4828
European-Finnish (FIN)
AF:
0.00255
AC:
27
AN:
10602
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0186
AC:
1267
AN:
68020
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0126
Hom.:
8
Bravo
AF:
0.0118
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0184
EpiControl
AF:
0.0169

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 10, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 10, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 1 Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Jun 04, 2015
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
12
DANN
Benign
0.65
PhyloP100
0.84
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41293106; hg19: chr20-30412101; API